Quick Answer
Axogen, Inc. reported R&D Expense of $32.88 million for fiscal year 2025.
Axogen, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $32.88M | +18.4% |
| 2024 | $27.77M | +1.6% |
| 2023 | $27.34M | +6.7% |
| 2022 | $25.63M | +6.0% |
| 2021 | $24.18M | +35.5% |
| 2020 | $17.85M | +1.9% |
| 2019 | $17.51M | +48.8% |
| 2018 | $11.77M | +75.7% |
| 2017 | $6.70M | +59.0% |
| 2016 | $4.21M | +30.1% |
| 2015 | $3.24M | +6.7% |
| 2014 | $3.03M | +42.7% |
| 2013 | $2.13M | +48.9% |
| 2012 | $1.43M | +104.7% |
| 2011 | $697.4K | +59.9% |
| 2010 | $436.0K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.57M | +8.1% | +10.4% |
| June 30, 2025 | $6.85M | +2.9% | +12.5% |
| March 31, 2025 | $6.09M | -17.8% | -12.9% |
| September 30, 2024 | $7.00M | +4.5% | +5.1% |
| June 30, 2024 | $6.66M | -6.8% | -10.1% |
| March 31, 2024 | $7.41M | +17.1% | +10.7% |
| September 30, 2023 | $6.69M | -5.0% | -6.3% |
| June 30, 2023 | $7.14M | +1.7% | +12.9% |
- Axogen, Inc. showed an increase of +18.4% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, Axogen, Inc.’s r&d expense has grown by 7442.3% (from $436.0 thousand to $32.88 million).
- The most recent figure is from Axogen, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: